Topoisomerase Inhibitor drugs compared

Compare all 5 Topoisomerase Inhibitor drugs side by side, used for conditions such as breast neoplasms, carcinoma, non-small-cell lung, colonic neoplasms. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.

Full ranking · 5 drugs

Frequently asked questions

What is the Topoisomerase Inhibitor drug class?

Topoisomerase Inhibitor is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 5 Topoisomerase Inhibitor products, each independently rated.

Are all Topoisomerase Inhibitor drugs the same?

No. Topoisomerase Inhibitor drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.

What conditions do Topoisomerase Inhibitor drugs treat?

Per NIH RxClass drug-classification data, Topoisomerase Inhibitor drugs are used for conditions including breast neoplasms, carcinoma, non-small-cell lung, colonic neoplasms, leukemia, lymphoma, neoplasm metastasis.

Sources: the Topoisomerase Inhibitor class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class); how the class works is summarized from Topoisomerase Inhibitors - LiverTox - NCBI Bookshelf. Ratings are pharmaranks’ independent FDA recall-safety analysis.